Загрузка...
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based study
Phosphodiesterase-5 inhibitors are commonly used in pulmonary arterial hypertension but, as suggested by the RESPITE study, phosphodiesterase-5 inhibitor therapy (mono-/combination) does not always have a satisfactory treatment effect. This study aimed to investigate the clinical course of pulmonary...
Сохранить в:
| Опубликовано в: : | Pulm Circ |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534092/ https://ncbi.nlm.nih.gov/pubmed/33062261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020958557 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|